Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinoma.
Saved in:
| Title: | Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinoma. |
|---|---|
| Authors: | Lahiji R; Department of Urology, Emory University School of Medicine, Atlanta, GA., Son LL; Department of Urology, Emory University School of Medicine, Atlanta, GA., Mumford S; Department of Urology, Emory University School of Medicine, Atlanta, GA., Kearns EJ; Department of Urology, Medical College of Georgia, Augusta, GA., Patil D; Department of Urology, Emory University School of Medicine, Atlanta, GA., Ambadi S; Department of Urology, University of California San Diego, San Diego, CA., Nguyen JT; Department of Urology, Emory University School of Medicine, Atlanta, GA., Esen B; Department of Urology, Emory University School of Medicine, Atlanta, GA; Department of Urology, Koc University School of Medicine, Istanbul, Turkey., Luke W; Department of Urology, Emory University School of Medicine, Atlanta, GA., Storino Ramacciotti L; Department of Urology, Emory University School of Medicine, Atlanta, GA., Goodstein T; Department of Urology, Emory University School of Medicine, Atlanta, GA., Morton EA; Department of Urology, Emory University School of Medicine, Atlanta, GA., Braunschweig A; Department of Urology, Emory University School of Medicine, Atlanta, GA., Nabavizadeh R; Department of Urology, Duke Cancer Center, Durham, NC., Narayan VN; Department of Urology, Emory University School of Medicine, Atlanta, GA., Grajales V; Department of Urology, Emory University School of Medicine, Atlanta, GA., Joshi SS; Department of Urology, Emory University School of Medicine, Atlanta, GA., Hajiha M; Department of Urology, Emory University School of Medicine, Atlanta, GA., Ogan K; Department of Urology, Emory University School of Medicine, Atlanta, GA., Master VA; Department of Urology, Emory University School of Medicine, Atlanta, GA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA. Electronic address: vmaster@emory.edu. |
| Source: | Urologic oncology [Urol Oncol] 2026 Jun; Vol. 44 (6), pp. 128-134. Date of Electronic Publication: 2026 Apr 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
